Airway Cell Biology and Immunopathology 2018
DOI: 10.1183/13993003.congress-2018.pa4244
|View full text |Cite
|
Sign up to set email alerts
|

Bifidobacterium breve significantly reduces cigarette smoke-induced COPD in C57Bl/6 mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Recently, it was reported that metabolites of probiotics carried through the circulation to the lungs might help with COVID-19 by inhibiting viral replication or enhancing the immune response [23]. This inhibition of inflammation has been demonstrated in animal studies that induced COPD with DPM and cigarette smoke; Bifidobacterium breve and Lactobacillus rhamnosus reduced gene expression related to mucin production and inflammatory factors, NF-κB, and cytokines [18,24]. Lactobacillus casei HY2782 and Bifidobacterium lactis HY8002 decreased oxidative stress and pro-inflammatory cytokines in the lung in vivo [25].…”
Section: Discussionmentioning
confidence: 95%
“…Recently, it was reported that metabolites of probiotics carried through the circulation to the lungs might help with COVID-19 by inhibiting viral replication or enhancing the immune response [23]. This inhibition of inflammation has been demonstrated in animal studies that induced COPD with DPM and cigarette smoke; Bifidobacterium breve and Lactobacillus rhamnosus reduced gene expression related to mucin production and inflammatory factors, NF-κB, and cytokines [18,24]. Lactobacillus casei HY2782 and Bifidobacterium lactis HY8002 decreased oxidative stress and pro-inflammatory cytokines in the lung in vivo [25].…”
Section: Discussionmentioning
confidence: 95%